Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
Reacta Biotech Limited was incorporated in June 2013 by its three founders: Professor Clare Mills, Professor Ashley Woodcock and Peter McPartland. Following an extensive planning phase, the Company’s seed capital was raised in February-April 2014. This funding, from a small syndicate of private investors, enabled the Company to formally commence its operations.
The Company’s first product will be an oral food challenge kit for the confirmation of peanut allergy.